what is willow glp 1 Willow’s 90-Day GLP-1 Program: A Shift Toward Sustainable Weight Loss?? Willow GLP-1 Review: Flat-Rate Pricing,

Boston (MA): Harvard T.H

This review concludes that GLP-1-based therapy has beneficial effects on inflammatory disease

Currently available GLP-1 receptor agonists in the UK include: Exenatide (short-acting and extended-release formulations) - licensed for type 2 diabetes Liraglutide (once-daily injection) - licensed for type 2 diabetes (Victoza) and separately for weight management (Saxenda 3mg) Dulaglutide (once-weekly injection) - licensed for type 2 diabetes, including cardiovascular risk reduction in those with established cardiovascular disease or multiple risk factors Semaglutide (once-weekly injection and oral formulation) - licensed for type 2 diabetes (Ozempic, Rybelsus) and separately for weight management (Wegovy 2.4mg) A related but distinct medication is tirzepatide (once-weekly injection), which is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes management

they are powerful hormonal agents that fundamentally alter the communication between your gut and your brain